Atara Biotherapeutics (ATRA) EBT (QoQ) (2013 - 2026)
Atara Biotherapeutics (ATRA) EBT (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - |
| 10 | Atara Biotherapeutics | 143.41 Mn | 126.86 Mn | 439,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.60% |
| Mar 31, 2026 | -22.34% |
| Dec 31, 2025 | 20.75% |
| Sep 30, 2025 | -278.87% |
| Jun 30, 2025 | -93.71% |
| Mar 31, 2025 | 399.01% |
| Dec 31, 2024 | 42.02% |
| Sep 30, 2024 | -15.10% |
| Jun 30, 2024 | 39.96% |
| Mar 31, 2024 | 47.50% |
| Dec 31, 2023 | 13.43% |
| Sep 30, 2023 | 1.82% |
| Jun 30, 2023 | 4.87% |
| Mar 31, 2023 | -0.24% |
| Dec 31, 2022 | 11.31% |
| Sep 30, 2022 | -555.33% |
| Jun 30, 2022 | 120.96% |
| Mar 31, 2022 | 5.80% |
| Dec 31, 2021 | -10.47% |
| Sep 30, 2021 | -1.06% |